Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus [3]

Indian Pediatrics

Volumn 44, Issue 1, 2007, Pages 54-55

  Tiker, Filiz ^a   Yildirim, Selman Vefa ^a  

^a Baskent Universitesi Adana Hastanesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN;

CASE REPORT; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPONATREMIA; INFANT; KIDNEY DISEASE; KIDNEY FUNCTION; LABORATORY TEST; LETTER; PATENT DUCTUS ARTERIOSUS; SYMPTOMATOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INFANT, NEWBORN; KIDNEY; RENAL INSUFFICIENCY;

EID: 33846467575     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Van Bel F, Guit GL, Schipper J, Van de Bor M, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991; 118: 621-626.
2. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in pretem infants treated for patent ductus arteriosus: a randomised control trial. Eur J Pediatr 2002; 161: 202-207.
3. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2005; (4): CD003481.
4. Chamaa NS, Mosig D, Drukker A, Guignard JP. The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 2000; 48: 600-605.
5. Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 2005; 30: 121-132.